Department of Biliary-Pancreatic Minimally Invasive Surgery, The First Affiliated Hospital of Shantou University Medical College, Shantou, P.R. China.
Oncol Res. 2019 Mar 29;27(4):509-514. doi: 10.3727/096504018X15278771272963. Epub 2018 Jun 1.
Hepatocellular carcinoma (HCC) is one of the major malignant tumors that lead to death. Chronic hepatitis B virus infection is an important risk factor for HCC initiation. HBx protein, encoded by the HBV gene, is a significant factor that promotes HBV-related HCC, although the exact molecular mechanism remains unclear. This article summarizes the pathological roles and related mechanisms of HBx in HCC. HBx plays a carcinogenic role by promoting cell proliferation, metastasis, and angiogenesis and inhibiting apoptosis in HCC. A detailed study of the biological functions of HBx will help to elucidate the mechanism of hepatocarcinogenesis and lead to the development of novel therapeutic targets for the treatment of HBV-related HCC.
肝细胞癌 (HCC) 是导致死亡的主要恶性肿瘤之一。慢性乙型肝炎病毒感染是 HCC 发生的重要危险因素。HBx 蛋白是由 HBV 基因编码的,是促进 HBV 相关 HCC 的重要因素,尽管确切的分子机制尚不清楚。本文总结了 HBx 在 HCC 中的病理作用和相关机制。HBx 通过促进 HCC 细胞的增殖、转移和血管生成,以及抑制细胞凋亡,发挥致癌作用。详细研究 HBx 的生物学功能将有助于阐明肝癌的发生机制,并为治疗 HBV 相关 HCC 开发新的治疗靶点。